BROS

The Week

Dutch Bros added 0.8% this week to close at $41.49. The path was a pop-and-fade: the stock rose through Monday and Tuesday to touch the week’s high of $44.098 on Tuesday, then pulled back from Wednesday onward to give back most of the gain by Friday’s close of $41.49. Weekly amplitude was 9.6%, and average daily volume of roughly 4.4m shares was in line with the recent median.

Key Events

This week’s news centred on a product launch, valuation, and analyst moves. On 19 October, commentary noted Dutch Bros could be undervalued after rolling out its ‘Unicorn Blood’ drink. On 22 October, Citigroup set a new $69.00 price target, but RBC cut its rating on competition worries and the shares drifted lower; on 23 October, KeyCorp trimmed its target to $59.00. The same day, Executive Chairman Travis Boersma reported disposing of about $6.41m in common shares. There was no earnings or major operating data from the company this week; the focus sat mostly with broker calls and insider selling.

Analyst Ratings

As of 23 October, 26 firms cover Dutch Bros: 21 rate it buy, 3 rate it over, 1 rates it hold, and 1 rates it under, with no sell ratings. Consensus stands at strong buy, with a consensus target of $66.32, roughly 59.8% above spot. The target range is wide, from $29.00 at the low end to $95.00 at the high end, pointing to a visible split on the company’s long-term growth runway. Within the restaurant sector, its rating rank sits at 13th out of 46 names, in the upper half.

The Week Ahead

Next week’s macro calendar is busy: the Dallas Fed manufacturing index lands on 26 October, followed on 27 October by durable goods orders, FHFA and Case Shiller home price data, new home sales, and consumer confidence. For Dutch Bros, the bigger date is 4 November after market close, when the company reports fiscal Q3 2026 results; the Street estimates EPS of $0.2058 on revenue of $549m. With this week’s broker calls split two ways, the report becomes the key check on the growth story.

In Short

The setup for Dutch Bros is mixed: the stock eked out a small weekly gain but faded from its highs, while consensus remains strongly positive and the consensus target sits well above spot, yet the target range is unusually wide, with RBC and KeyCorp cutting ratings and the executive chairman trimming shares this week. Valuation looks stretched at roughly 78.46x P/E and 9.09x P/B. From here, the focus is on whether Q3 results can deliver the same-store growth and store expansion pace needed to justify that multiple.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.